These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18753644)

  • 1. An HIV vaccine--challenges and prospects.
    Johnston MI; Fauci AS
    N Engl J Med; 2008 Aug; 359(9):888-90. PubMed ID: 18753644
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular snapshots from CROI 2007.
    Jefferys R
    IAVI Rep; 2007; 11(1):1, 6-9. PubMed ID: 20213873
    [No Abstract]   [Full Text] [Related]  

  • 3. Challenges and opportunities for development of an AIDS vaccine.
    Nabel GJ
    Nature; 2001 Apr; 410(6831):1002-7. PubMed ID: 11309631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grim news for vaccine.
    AIDS Patient Care STDS; 2002 Oct; 16(10):513-4. PubMed ID: 12442739
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV vaccine may raise risk.
    Ledford H
    Nature; 2007 Nov; 450(7168):325. PubMed ID: 18004331
    [No Abstract]   [Full Text] [Related]  

  • 6. CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
    Yang OO
    Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041
    [No Abstract]   [Full Text] [Related]  

  • 7. One step forward, two steps back--will there ever be an AIDS vaccine?
    Steinbrook R
    N Engl J Med; 2007 Dec; 357(26):2653-5. PubMed ID: 18160684
    [No Abstract]   [Full Text] [Related]  

  • 8. An HIV vaccine--evolving concepts.
    Johnston MI; Fauci AS
    N Engl J Med; 2007 May; 356(20):2073-81. PubMed ID: 17507706
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV vaccine failure prompts Merck to halt trial.
    Nature; 2007 Sep; 449(7161):390. PubMed ID: 17898737
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccine trial discontinued.
    AIDS Patient Care STDS; 2007 Oct; 21(10):778-9. PubMed ID: 17992718
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV/AIDS research. Surprising AIDS vaccine success praised and pondered.
    Cohen J
    Science; 2009 Oct; 326(5949):26-7. PubMed ID: 19797628
    [No Abstract]   [Full Text] [Related]  

  • 12. Aiming for successful vaccine-induced HIV-1-specific cytotoxic T lymphocytes.
    Yang OO
    AIDS; 2008 Jan; 22(3):325-31. PubMed ID: 18195558
    [No Abstract]   [Full Text] [Related]  

  • 13. Current approaches to developing a preventative HIV vaccine.
    Tonini T; Barnett S; Donnelly J; Rappuoli R
    Curr Opin Investig Drugs; 2005 Feb; 6(2):155-62. PubMed ID: 15751738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hitting HIV where it hurts: an alternative approach to HIV vaccine design.
    Altfeld M; Allen TM
    Trends Immunol; 2006 Nov; 27(11):504-10. PubMed ID: 16997629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development.
    Heeney JL; Hahn BH
    AIDS; 2000; 14 Suppl 3():S125-7. PubMed ID: 11086855
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV/AIDS vaccines: 2007.
    Robinson HL
    Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV/AIDS. Hedged bet: an unusual AIDS vaccine trial.
    Cohen J
    Science; 2005 Aug; 309(5737):1003. PubMed ID: 16099960
    [No Abstract]   [Full Text] [Related]  

  • 18. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
    Emini EA; Koff WC
    Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention. The elusive AIDS vaccine.
    TreatmentUpdate; 2008 Mar; 20(2):10-3. PubMed ID: 18661649
    [No Abstract]   [Full Text] [Related]  

  • 20. Researchers announce first correlates of protection for HIV vaccine.
    Roehr B
    BMJ; 2011 Sep; 343():d5880. PubMed ID: 21920885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.